Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats
Minimal hepatic encephalopathy is more common than the acute syndrome. Losartan, the first angiotensin-II receptor blocker (ARB), and candesartan, another widely-used ARB, have protected against developing fibrogenesis, but there is no clear data about their curative antifibrotic effects. The curren...
Main Authors: | H.A. Murad, Z.J. Gazzaz, S.S. Ali, M.S. Ibraheem |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2017-09-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017001100611&lng=en&tlng=en |
Similar Items
-
Effect of lesimarin against thioacetamide-induced liver cirrhosis in rat
by: Sang-Ho Ra, et al.
Published: (2019-12-01) -
Antioxidant and Hepatoprotective Effects of Tranilast against Thioacetamide-Induced Liver Fibrosis in Rats
by: Ramadan A., et al.
Published: (2017-10-01) -
Acute bone damage through liver-bone axis induced by thioacetamide in rats
by: Xiaoli Jin, et al.
Published: (2022-05-01) -
Candesartan in treating hypertension
by: L O Minushkina
Published: (2014-03-01) -
CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS
by: V. S. Zadionchenko, et al.
Published: (2015-12-01)